OLAMLO, OLMAKAR, OLMESARTAN/AMLODIPINE ASTRON, OLMESARTAN/AMLODIPINE INTAS (Accord Healthcare Pty Ltd)
Product name
OLAMLO, OLMAKAR, OLMESARTAN/AMLODIPINE ASTRON, OLMESARTAN/AMLODIPINE INTAS
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
153 (255 working days)
Active ingredients
Olmesartan medoxomil, Amlodipine besilate
Registration type
New generic medicine
Indication
OLAMLO, OLMAKAR, OLMESARTAN/AMLODIPINE ASTRON, OLMESARTAN/AMLODIPINE INTAS is indicated for the treatment of hypertension. Treatment should not be initiated with this fixed-dose combination (see Section 4.2 Dose and Method of Administration).